Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference

Rhea-AI Summary

Madrigal Pharmaceuticals (NASDAQ: MDGL) announced its participation in the upcoming 46th Annual Global Goldman Sachs Health Care Conference. The company's presentation is scheduled for Wednesday, June 11, 2025, at 10:40 A.M. EDT. Interested parties can access the live webcast through the provided link or via Madrigal's Investor Relations Events and Presentations page. A replay of the presentation will be made available following the event.

News Market Reaction

-0.94%

1 alert

-0.94% News Effect

On the day this news was published, MDGL declined 0.94%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

CONSHOHOCKEN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the 46^th Annual Global Goldman Sachs Health Care Conference on Wednesday, June 11, 2025 at 10:40 A.M. EDT.

The presentation will be webcast live and may be accessed here or by visiting Madrigal’s Investor Relations Events and Presentations page. A replay of the webcast will be available after the event.

About Madrigal
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by the FDA for the treatment of MASH with moderate to advanced fibrosis (consistent with stages F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (consistent with stage F4c). For more information, visit www.madrigalpharma.com.

Investor Contact

Tina Ventura, IR@madrigalpharma.com

Media Contact
Christopher Frates, media@madrigalpharma.com

FAQ

When is Madrigal Pharmaceuticals (MDGL) presenting at the Goldman Sachs Health Care Conference 2025?

Madrigal Pharmaceuticals will present at the Goldman Sachs Health Care Conference on Wednesday, June 11, 2025 at 10:40 A.M. EDT.

How can I watch Madrigal Pharmaceuticals' (MDGL) presentation at the Goldman Sachs conference?

The presentation can be accessed through the webcast link provided by the company or through Madrigal's Investor Relations Events and Presentations page.

Will there be a replay available of Madrigal Pharmaceuticals' (MDGL) Goldman Sachs conference presentation?

Yes, a replay of the webcast will be available after the event.

What is the purpose of Madrigal Pharmaceuticals' (MDGL) participation in the Goldman Sachs Health Care Conference?

The conference provides Madrigal Pharmaceuticals an opportunity to present their company updates and developments to investors and industry professionals at a major healthcare investment event.